Research programme: PDGFR antagonists - Array Biopharma
Alternative Names: ARRY-768Latest Information Update: 02 Aug 2019
At a glance
- Originator Array BioPharma
- Class Small molecules
- Mechanism of Action Angiogenesis inhibitors; Platelet-derived growth factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer; Fibrosis
Most Recent Events
- 30 Jul 2019 Array Biopharma has been acquired by Pfizer
- 12 Aug 2011 No development reported - Preclinical for Cancer in USA (PO)
- 12 Aug 2011 No development reported - Preclinical for Fibrosis in USA (PO)